Shana Jacobs, M.D.

Children’s National Researchers Receive Nearly $2 Million NIH Grant for Pediatric Acute Myelogenous Leukemia Treatment Innovations

A $1.92 million grant from the National Institutes of Health (NIH) was awarded to a research team that focuses on new approaches for treatment of relapsed pediatric acute myelogenous leukemia (AML).

Anne Angiolillo

Leukemia

Leukemia is the most common form of pediatric cancer. Leukemia is cancer of the blood and develops in the bone marrow. Learn more about this condition.

Acute Lymphoblastic Leukemia (ALL)

Cancer specialists at Children’s National in Washington, D.C., provide expert treatment for children who have acute lymphoblastic leukemia. Learn more about this condition, including its symptoms, what causes and how we treat it.